HSBC Holdings
ORGO icon

HSBC Holdings’s Organogenesis Holdings ORGO Stock Holding History

HSBC Holdings’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Buy
139,166
+87,203
+168% +$213K ﹤0.01% 2480
2026
Q1 		$122K Buy
+51,963
New +$180K ﹤0.01% 2726
2025
Q2 		– Sell
-26,401
Closed -$113K – 3187
2025
Q1 		$113K Buy
+26,401
New +$107K ﹤0.01% 2782
2024
Q1 		– Sell
-26,617
Closed -$110K – 3182
2023
Q4 		$110K Buy
+26,617
New +$74.5K ﹤0.01% 2587
2023
Q1 		– Sell
-15,294
Closed -$40.7K – 2944
2022
Q4 		$40.7K Buy
15,294
+1,893
+14% +$5.52K ﹤0.01% 2982
2022
Q3 		$44K Sell
13,401
-2,912
-18% -$13.2K ﹤0.01% 2833
2022
Q2 		$81K Buy
16,313
+676
+4% +$4.16K ﹤0.01% 3073
2022
Q1 		$121K Buy
+15,637
New +$121K ﹤0.01% 3093

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

HSBC Holdings's ORGO Position: Q2 2026 in Review

HSBC Holdings increased its Organogenesis Holdings (ORGO) stake by 168% in Q2 2026, buying an estimated $213K and bringing the position to 139,166 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #2480.

HSBC Holdings first reported a position in ORGO in Q1 2022 and has held it in 8 quarters since. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • HSBC Holdings held 139,166 shares of Organogenesis Holdings worth $324K as of Q2 2026.
  • HSBC Holdings bought 87,203 Organogenesis Holdings shares in Q2 2026, an estimated $213K.
  • Organogenesis Holdings made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2480 holding.
  • HSBC Holdings first reported a position in Organogenesis Holdings in Q1 2022 and has held it in 8 quarters since.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.